Companies: 10,795·Total market cap: $144.5T
Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

RETANASDAQHealthcare
$172.36
+$0.04(+0.02%)
Market Cap$6.6B
P/E Ratio—
52W High$172.46
52W Low$21.83
SEC Filings

Reata Pharmaceuticals, Inc. (RETA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001358762 · RETA · NASDAQ · as of Jun 9, 2026

Filing snapshot

702
Total Filings
15-12G
Latest Form
2023-10-06
Most Recent
2016
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001358762 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-02-24
Fiscal Year End
Feb 24, 2023
Accession No.
0000950170-23-004236
Primary Document
reta-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001358762 · Accession 0000950170-23-004236

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-08
View 10-Q on SEC
8-KCurrent Report
8-K
2023-09-26Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-10-06
View
SC 13D/ASC 13D/A
SC 13D/A
2023-09-28
View
SC 13D/ASC 13D/A
SC 13D/A
2023-09-28
View
8-KCurrent Report
8-K
2023-09-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-09-26
View
POSASRPOSASR
POSASR
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
S-8 POSS-8 POS
S-8 POS
2023-09-26
View
Showing 1–15 of 336 filingsForm 4 / 144 hidden· 702 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001358762  |  Exchange: NASDAQ · Healthcare

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) has submitted 702 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001358762, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Reata Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Reata Pharmaceuticals, Inc. 10-K was filed on 2023-02-24 for fiscal year ending 2023. Historical RETA 10-K annual reports are available from 2006 through 2023.

Investors researching Reata Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ROIV SEC Filings →RXDX SEC Filings →IMGN SEC Filings →BPMC SEC Filings →CERE SEC Filings →RCM SEC Filings →ABCM SEC Filings →ISEE SEC Filings →
→ RETA Financials→ RETA Earnings→ RETA Insider Trades

Frequently Asked Questions

RETA SEC Filings · 8 questions

Reata Pharmaceuticals, Inc. (RETA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 702 filings and access original documents at no cost. Reata Pharmaceuticals, Inc.'s CIK is 0001358762.

RETA SEC filingsReata Pharmaceuticals, Inc. SEC documentsfind RETA 10-K